Semarion
Develops next-generation cell assay technology for drug discovery
$3.8MUndisclosed
Role not disclosedOI
Oxford Innovation Finance
Activity from announced rounds
Activity in this selectionxyz-venture-capital-d246227f
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $3.8M 1 disclosed · full round size, not this investor’s share